HER2 copy number variation in non-small cell lung cancer (NSCLC)

被引：1

作者：

Tagliamento, M. ^{[1
]}

Auclin, E. ^{[2
]}

Valent, A. ^{[3
]}

Ferrara, R. ^{[4
]}

Cotteret, S. ^{[3
]}

Rouleau, E. ^{[3
]}

Caramella, C. ^{[5
]}

Melia, M. Riudavets ^{[1
]}

Gazzah, A. ^{[6
]}

Adam, J. ^{[3
]}

Jovelet, C. ^{[3
]}

Bayle, A. ^{[6
]}

Lacroix, L. ^{[3
]}

Auger, N. ^{[3
]}

Barlesi, F. ^{[7
]}

Planchard, D. ^{[1
]}

Besse, B. ^{[8
]}

Mezquita, L. ^{[9
]}

机构：

[1] Gustave Roussy, Dept Canc Med, Villejuif, France

[2] Hop Europeen Georges Pompidou, AP HP, Oncol Dept, Paris, France

[3] Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France

[4] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy

[5] Hop Marie Lannelongue, Dept Radiol, Le Plessis Robinson, France

[6] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France

[7] Gustave Roussy, Dept Canc Med, Villejuif, France

[8] Gustave Roussy, Canc Med Dept, Villejuif, France

[9] Hosp Clin Barcelona, Div Med Oncol, Lab Translat Genom & Targeted Therapies Solid Tum, IDIBAPS, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.1215

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1090P

引用

页码：S1050 / S1050

页数：1

共 50 条

[41] Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations
Riudavets, M.
Sullivan, I.
Abdayem, P.
Planchard, D.
[J]. ESMO OPEN, 2021, 6 (05)
[42] Characterization of 648 non-small cell lung cancer (NSCLC) cases with 28 unique HER2 exon 20 insertions.
Ou, Sai-Hong Ignatius
Madison, Russell
Robichaux, Jacqulyne Ponville
Ross, Jeffrey S.
Miller, Vincent A.
Ali, Siraj Mahamed
Schrock, Alexa Betzig
Heymach, John
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[43] Real-World Characteristics and Outcomes Among Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) and HER2 Mutations
Bath, Christina
Le, Xiuning
Lovly, Christine M.
Patil, Tejas
Maruti, Sonia S.
Stanhope, Stephen A.
Herbert, Stephan
Nagasaka, Misako
[J]. JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E49 - E50
[44] EGFR, K-RAS and HER2 mutations as predictive factors for gefitinib sensitivity in non-small cell lung cancer (NSCLC)
Voutsina, A.
Kalikaki, A.
Ampatziadis-Michailidis, Y.
Souglakos, J.
Koytsopoylos, A.
Trypaki, M.
Pallis, A.
Stathopoylos, S.
Mavroudis, D.
Georgoulias, V.
[J]. EJC SUPPLEMENTS, 2007, 5 (08): : 35 - 35
[45] P53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel
Yumuk, R
Turhal, N
Ahiskali, R
Gumus, M
Hatabay, N
Turken, O
Ozkan, A
Salepci, T
Aliustaoglu, M
[J]. LUNG CANCER, 2005, 49 : S152 - S152
[46] Phase 1/2 Trial of the Oral EGFR/HER2 Inhibitor AP32788 in Non-Small Cell Lung Cancer (NSCLC)
Doebele, Robert
Horn, Leora
Spira, Alexander
Piotrowska, Zofia
Costa, Daniel
Neal, Joel
Reichmann, William
Kerstein, David
Li, Shuanglian
Janne, Pasi
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1072 - S1073
[47] COPY NUMBER ABBERATION IN NON-SMALL CELL LUNG CANCER WITH ALK FUSION PROTEIN
Yokoi, Sana
Kimura, Hideki
Kageyama, Hajime
Iizasa, Toshihiko
Ohira, Miki
Nagase, Hiroki
Nakagawara, Akira
[J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S971 - S971
[48] Cigarette smoking increases copy number alterations in non-small cell lung cancer
Huang, Yen-Tsung
Lin, Xihong
Chirieac, Lucian R.
McGovern, Ray
Wain, John C.
Heist, Rebecca S.
Skaug, Vidar
Zienolddiny, Shanbeh
Haugen, Aage
Su, Li
Christiani, David C.
[J]. CANCER RESEARCH, 2010, 70
[49] β-catenin in non-small cell lung cancer (NSCLC)
Swinson, DEB
Lolljee, J
Edwards, JG
Jones, JL
Cox, G
Richardson, D
O'Byrne, KJ
[J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
[50] Role of mitochondrial DNA copy number alteration in non-small cell lung cancer
Lin, Chen-Sung
Yeh, Yi-Chen
Pan, Siao-Cian
Lu, Shih-Yu
Chen, Yann-Jang
Chueh, Wen-Yu
Wei, Yau-Huei
[J]. FORMOSAN JOURNAL OF SURGERY, 2020, 53 (05) : 165 - 176

← 1 2 3 4 5 →